已收盤 12-24 16:00:00 美东时间
+0.480
+1.36%
今日重点评级关注:富国银行:维持Milestone Pharmaceuticals"超配"评级,目标价从4美元升至8美元;富国银行:维持Kyverna Therapeutics"超配"评级,目标价从31美元升至33美元
12-17 10:46
Truist Securities analyst Michael Lewis maintains CubeSmart (NYSE:CUBE) with a Buy and lowers the price target from $48 to $42.
12-16 22:40
CubeSmart (NYSE:CUBE) announced today that its Board of Trustees declared a quarterly dividend of $0.53 per common share for the period ending December 31, 2025. The dividend is payable on January 16, 2026 to common
12-15 21:32
CubeSmart announced a quarterly dividend of $0.53 per common share, payable on January 16, 2026, to shareholders of record on January 2, 2026. This marks the 16th consecutive annual dividend increase. The company, one of the top three self-storage property owners and operators in the U.S., owns or manages 1,527 facilities and simplifies storage challenges through innovative solutions and excellent service.(cube smart的)
12-15 13:30
今日重点评级关注:Stifel:维持X4 Pharmaceuticals"买入"评级,目标价从7.5美元升至10美元;花旗:维持UP Fintech Holding"买入"评级,目标价从17.4美元升至17.5美元
12-08 08:34
Mizuho analyst Ravi Vaidya maintains CubeSmart (NYSE:CUBE) with a Neutral and lowers the price target from $43 to $38.
12-05 22:31
Cubesmart ( ($CUBE) ) just unveiled an announcement. CubeSmart’s December 2025 ...
12-03 05:57
华尔街最受关注、且能影响市场走势的研究评级报告现已汇总于此。以下是由 The Fly 整理的今日投资者需关注的研究评级动态。 五大上调评级案例 诺斯兰(...
11-10 22:53
Keybanc analyst Todd Thomas downgrades CubeSmart (NYSE:CUBE) from Overweight to Sector Weight.
11-10 18:51
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
11-04 10:31